BRCA1 and neoplasm: Due to the lack of the ring binding domain, BARD1β does not contain the binding site necessary for interaction with BRCA1 and may display oncogenic effect via affecting BARD1/BRCA1 tumor suppressor function either independent or dependent on FL BARD1 protein.